Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kentnf
    Member
    • Jan 2009
    • 26

    #1

    Different results produced by tophat?

    I use tophat to map my strand-specific RNA-seq seqs and its reverse complementary seqs to genome, but the results have a little difference.

    For example, I have 5700000 seqs in one sample after sequencing, 5000000 of them mapped to genome by tophat. For reverse complementary seqs, maybe 4998000 of them were mapped to genome.

    command I used:
    $tophat -o output1 --segment-mismatches 0 genome_index RNA-seq.fa

    Then I compare mapped seqs of different results. There are 50000 seqs in the results A (5000000 mapped, normal strand) are not present in result B (4998000 mapped, reverse complementary strand). Another 50000 seqs are not present in result A but included in result B.

    Who can tell me why the results is different ? Thanks.
  • Daehwan
    Member
    • Oct 2010
    • 27

    #2
    I think it's probably due to quality values, you know, the quality value of each base usually decreases from left to right. So, if we reverse-complement a read, the read will have low quality values in its first several bases and therefore it's less likely for the read to be mapped to a genome. Perhaps you check this running Bowtie with the original reads and the reverse-complemented reads as TopHat is based on Bowtie.

    Bowtie allows 0~3 mismatches in the SEED of a read, which is 28bp by default, and allows additional mismatches in the rest depending on the sum of quality values, which I understand.


    Regarding each 50,000 seq difference between the results A and B, TopHat divides unmapped reads into several segments to find novel junctions, and a set of segments from the original reads can be different from that of segments from the reverse-complemented reads depending on the read length and the segment length, rendering different set of putative junctions.

    Other than this, the new version of TopHat at <http://tophat.cbcb.umd.edu/index.html> supports strand-specific RNA-Seq if you want to try it.

    Thanks,
    Daehwan
    Last edited by Daehwan; 10-27-2010, 10:06 AM.

    Comment

    • kentnf
      Member
      • Jan 2009
      • 26

      #3
      Thank you Daehwan.

      Before map reads to genome using tophat, contamination has already been cleaned. So I use fasta as input of tophat. And then I use bowtie map forward and reverse seqs to genome, the results are same.

      After check the cigar field of sam file, I think you are right. All the different parts of forward and reverse results are unmapped reads. When I set the parameter -a to 4, the different parts of results are reduced.
      Originally posted by Daehwan View Post
      Regarding each 50,000 seq difference between the results A and B, TopHat divides unmapped reads into several segments to find novel junctions, and a set of segments from the original reads can be different from that of segments from the reverse-complemented reads depending on the read length and the segment length, rendering different set of putative junctions.
      And I will try the new version of tophat. Thanks again

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      35 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...